- Home
- RPRX vs GNRC Comparison
RPRX vs GNRC Comparison
Compare RPRX & GNRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RPRX
- GNRC
- Stock Information
- Founded
- RPRX 1996
- GNRC 1959
- Country
- RPRX United States
- GNRC United States
- Employees
- RPRX N/A
- GNRC N/A
- Industry
- RPRX Biotechnology: Pharmaceutical Preparations
- GNRC Metal Fabrications
- Sector
- RPRX Health Care
- GNRC Consumer Discretionary
- Exchange
- RPRX Nasdaq
- GNRC Nasdaq
- Market Cap
- RPRX 13.9B
- GNRC 11.6B
- IPO Year
- RPRX 2020
- GNRC 2010
- Fundamental
- Price
- RPRX $37.85
- GNRC $195.84
- Analyst Decision
- RPRX Strong Buy
- GNRC Strong Buy
- Analyst Count
- RPRX 4
- GNRC 18
- Target Price
- RPRX $46.75
- GNRC $173.72
- AVG Volume (30 Days)
- RPRX 2.5M
- GNRC 1.3M
- Earning Date
- RPRX 08-06-2025
- GNRC 07-30-2025
- Dividend Yield
- RPRX 2.38%
- GNRC N/A
- EPS Growth
- RPRX 43.84
- GNRC 54.62
- EPS
- RPRX 2.16
- GNRC 6.03
- Revenue
- RPRX $2,304,578,000.00
- GNRC $4,411,654,000.00
- Revenue This Year
- RPRX $28.60
- GNRC $5.36
- Revenue Next Year
- RPRX $8.07
- GNRC $6.58
- P/E Ratio
- RPRX $17.14
- GNRC $32.06
- Revenue Growth
- RPRX 2.99
- GNRC 9.69
- 52 Week Low
- RPRX $24.05
- GNRC $99.50
- 52 Week High
- RPRX $38.00
- GNRC $199.89
- Technical
- Relative Strength Index (RSI)
- RPRX 57.95
- GNRC 78.41
- Support Level
- RPRX $36.27
- GNRC $192.22
- Resistance Level
- RPRX $38.00
- GNRC $197.96
- Average True Range (ATR)
- RPRX 0.68
- GNRC 6.82
- MACD
- RPRX -0.02
- GNRC 2.63
- Stochastic Oscillator
- RPRX 64.97
- GNRC 89.95
About RPRX Royalty Pharma plc
Royalty Pharma PLC is the largest buyer of biopharmaceutical royalties. The firm has a portfolio of royalties that entitles it to payments based on the sales of biopharma products. Royalty Pharma receives royalties on more than 35 commercial products, including AbbVie and Johnson & Johnson's Imbruvica (for chronic lymphocytic leukemia and other blood cancers), Biogen's Tysabri (for relapsing forms of multiple sclerosis), Vertex's cystic fibrosis franchise, and 10 development-stage product candidates.
About GNRC Generac Holdlings Inc.
Generac designs and manufactures power generation equipment serving residential, commercial, and industrial markets. It offers standby generators, portable generators, lighting, outdoor power equipment, and a suite of clean energy products. Sales generated in the United States account for the majority of total sales.